Learn and Participate
There is increased attention on alopecia areata research. Have you considered becoming involved in alopecia areata research to help in the quest to find new treatments? If so, there are several ways you can participate.
There is increased attention on alopecia areata research. Have you considered becoming involved in alopecia areata research to help in the quest to find new treatments? If so, there are several ways you can participate.
If you are interested in participating in a clinical trial to test a new treatment in development for alopecia areata, be sure you understand how clinical trials work. The National Institutes of Health has published an insightful guide, “Why should I participate in a clinical trial?”
Search for alopecia areata clinical trials on ClinicalTrials.gov here.
Please note that some clinical trials for alopecia areata are offering an extension study period, allowing all participants the option to have long-term access to the investigational medicine beyond the initial clinical trial timeframe. Ask your clinical trial investigator for more information.
The U.S Food and Drug Administration (FDA) explored alopecia areata with patients through its Patient-Focused Drug Development (PFDD) program. At a meeting of patients held on Monday, September 11, 2017, the FDA gathered feedback on living with the disease and reactions to treatment options. The FDA continued to gather patient input after the meeting and published a "The Voice of the Patient" report with all patient feedback.